Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,718 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II/III study of second-line chemotherapy comparing irinotecan-alone with S-1 plus irinotecan in advanced gastric cancer refractory to first-line treatment with S-1 (JACCRO GC-05).
Tanabe K, Fujii M, Nishikawa K, Kunisaki C, Tsuji A, Matsuhashi N, Takagane A, Ohno T, Kawase T, Kochi M, Yoshida K, Kakeji Y, Ichikawa W, Chin K, Terashima M, Takeuchi M, Nakajima T. Tanabe K, et al. Among authors: fujii m. Ann Oncol. 2015 Sep;26(9):1916-1922. doi: 10.1093/annonc/mdv265. Epub 2015 Jun 24. Ann Oncol. 2015. PMID: 26109630 Free article. Clinical Trial.
Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START).
Koizumi W, Kim YH, Fujii M, Kim HK, Imamura H, Lee KH, Hara T, Chung HC, Satoh T, Cho JY, Hosaka H, Tsuji A, Takagane A, Inokuchi M, Tanabe K, Okuno T, Ogura M, Yoshida K, Takeuchi M, Nakajima T; JACCRO and KCSG Study Group. Koizumi W, et al. Among authors: fujii m. J Cancer Res Clin Oncol. 2014 Feb;140(2):319-28. doi: 10.1007/s00432-013-1563-5. Epub 2013 Dec 24. J Cancer Res Clin Oncol. 2014. PMID: 24366758 Free PMC article. Clinical Trial.
Dynamic changes in RAS gene status in circulating tumour DNA: a phase II trial of first-line FOLFOXIRI plus bevacizumab for RAS-mutant metastatic colorectal cancer (JACCRO CC-11).
Sunakawa Y, Satake H, Usher J, Jaimes Y, Miyamoto Y, Nakamura M, Kataoka M, Shiozawa M, Takagane A, Terazawa T, Watanabe T, Ishiguro K, Tanaka C, Takeuchi M, Fujii M, Danenberg K, Danenberg PV, Lenz HJ, Sekikawa T, Ichikawa W. Sunakawa Y, et al. Among authors: fujii m. ESMO Open. 2022 Jun;7(3):100512. doi: 10.1016/j.esmoop.2022.100512. Epub 2022 Jun 7. ESMO Open. 2022. PMID: 35688061 Free PMC article. Clinical Trial.
[Neoadjuvant chemotherapy for advanced gastric cancer using FLEP therapy].
Mochizuki F, Fujii M, Kasakura Y, Kochi M, Imai S, Eguchi T, Tsuneda Y, Kanamori N, Kaiga T, Kobayashi M. Mochizuki F, et al. Among authors: fujii m. Gan To Kagaku Ryoho. 2000 Oct;27(12):1812-5. Gan To Kagaku Ryoho. 2000. PMID: 11086418 Clinical Trial. Japanese.
[FLEP therapy for advanced and recurrent gastric cancer].
Mochizuki F, Fujii M, Kasakura Y, Kochi M, Wakabayashi K, Eguchi T, Tsuneda Y, Kanamori N, Kaiga T, Kobayashi M. Mochizuki F, et al. Among authors: fujii m. Gan To Kagaku Ryoho. 2001 Oct;28(11):1542-5. Gan To Kagaku Ryoho. 2001. PMID: 11707975 Clinical Trial. Japanese.
3,718 results